Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by InvrsContrarianon Dec 18, 2020 12:02pm
144 Views
Post# 32140313

RE:ARISTOTLE is COMING , FOCUS ON CANCER !!!

RE:ARISTOTLE is COMING , FOCUS ON CANCER !!!Stagezero has done tremendous work to reach their next Milestone. They have improved their website, added a great telehealth ecosystem unrivaled by any company in this industry and made the covid pivot seemsless all the while raising funds with clear goals that were achieved within stated time frames and limited(minimal) funds. STAGEZERO is in a position to take advantage of the current covid testing demand (to reinvest that revenue into Aristotle) and will flourish as the company has demonstrated that anything you throw at them they will find a solution and generate revenue in that process. Stagezero has proven that cash is king even when every one believes that making money of a horrible situation is unethical. But look at the vaccine companies, they are generating revenue so it comes down to providing a service that is unparalleled, secure, accountable and for the benefit of society as a whole. Stagezero has the holy Grail in cancer detection. First to market means Stagezero will be watched and under intense scrutiny. Because of covid they are and have worked very hard to prove that their answer to social distancing and health care can be accomplished effectively and efficiently.
MissUniverse wrote:
Great news people ! Aristotle is ready to launch in Q1  !

We have to focus on CANCER !


<< Previous
Bullboard Posts
Next >>